PredictImmune signs agreement with Theradiag to Commercialise PredictSURE IBD in French speaking Europe
PredictImmune, developers of pioneering prognostic tools for guiding treatment options in immune-mediated diseases, confirmed that it has entered into a commercial partnership with Theradiag, a pioneering European diagnostic company specialising in in vitro diagnostics and theranostics for autoimmune diseases and